A PHASE II TRIAL OF TAMOXIFEN AND BORTEZOMIB IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA

被引：0
|
作者：
Aregawi, Dawit [1 ]
Kreisl, Teri N. [2 ]
Innis, Ellen [3 ]
Fine, Howard A. [4 ]
机构：
[1] NCI, Neurooncol Branch, Bethesda, MD 20892 USA
[2] Columbia Univ, Neurol Inst, New York, NY USA
[3] Univ Maryland, Baltimore, MD 21201 USA
[4] NYU, Inst Canc, NYU Langone Med Ctr, New York, NY USA
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
10.1093/neuonc/nou237.6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AT-06
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PHASE II TRIAL OF DOSE-DENSE 1 WEEK ON/1 WEEK OFF TEMOZOLOMIDE FOR PATIENTS WITH RECURRENT HIGH GRADE GLIOMA
    Han, Seunggu
    Molinaro, Annette
    Berger, Mitchel
    Prados, Michael
    Chang, Susan
    Clarke, Jennifer
    Butowski, Nicholas
    NEURO-ONCOLOGY, 2013, 15 : 111 - 111
  • [32] A MULTICENTER STRATIFIED PHASE II STUDY OF CETUXIMAB FOR THE TREATMENT OF PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA
    Neyns, B.
    Sadones, J.
    Joosens, E.
    Bouttens, F.
    Verbeke, L.
    Baurain, J.
    Dhondt, L.
    Strauven, T.
    Chaskis, C.
    Michotte, A.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1067 - 1067
  • [33] A multicenter stratified phase II study of cetuximab for the treatment of patients with recurrent high-grade glioma
    Neyns, B.
    Sadones, J.
    Joosens, E.
    Bouttens, F.
    Verbeke, L.
    Baurain, J. F.
    D'Hondt, L.
    Chaskis, C.
    Michotte, A.
    De Greve, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] A phase I/II trial of vandetanib for patients with recurrent malignant glioma
    Kreisl, Teri N.
    McNeill, Katharine A.
    Sul, Joohee
    Iwamoto, Fabio M.
    Shih, Joanna
    Fine, Howard A.
    NEURO-ONCOLOGY, 2012, 14 (12) : 1519 - 1526
  • [35] Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma
    Sathornsumetee, Sith
    Desjardins, Annick
    Vredenburgh, James J.
    McLendon, Roger E.
    Marcello, Jennifer
    Herndon, James E.
    Mathe, Alyssa
    Hamilton, Marta
    Rich, Jeremy N.
    Norfleet, Julie A.
    Gururangan, Sridharan
    Friedman, Henry S.
    Reardon, David A.
    NEURO-ONCOLOGY, 2010, 12 (12) : 1300 - 1310
  • [36] A phase II trial of LY317615 in patients with recurrent high grade gliomas.
    Fine, HA
    Kim, L
    Royce, C
    Mitchell, S
    Duic, JP
    Albert, P
    Musib, L
    Thornton, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 109S - 109S
  • [37] Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas
    Ahluwalia, Manmeet S.
    Patton, Carol
    Stevens, Glen
    Tekautz, Tanya
    Angelov, Lilyana
    Vogelbaum, Michael A.
    Weil, Robert J.
    Chao, Sam
    Elson, Paul
    Suh, John H.
    Barnett, Gene H.
    Peereboom, David M.
    JOURNAL OF NEURO-ONCOLOGY, 2011, 102 (02) : 317 - 321
  • [38] Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas
    Manmeet S. Ahluwalia
    Carol Patton
    Glen Stevens
    Tanya Tekautz
    Lilyana Angelov
    Michael A. Vogelbaum
    Robert J. Weil
    Sam Chao
    Paul Elson
    John H. Suh
    Gene H. Barnett
    David M. Peereboom
    Journal of Neuro-Oncology, 2011, 102 : 317 - 321
  • [39] Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas
    Fine, HA
    Figg, WD
    Jaeckle, K
    Wen, PY
    Kyritsis, AP
    Loeffler, JS
    Levin, VA
    Black, PM
    Kaplan, R
    Pluda, JM
    Yung, WKA
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) : 708 - 715
  • [40] Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: A phase I/II study
    Hercbergs, AA
    Goyal, LK
    Suh, JH
    Lee, S
    Reddy, CA
    Cohen, BH
    Stevens, GH
    Reddy, SK
    Peereboom, DM
    Elson, PJ
    Gupta, MK
    Barnett, GH
    ANTICANCER RESEARCH, 2003, 23 (1B) : 617 - 626
12345